US 11,684,771 B2
System and method for treating various neurological disorders using synchronized nerve activation
Tamir Ben-David, Tel-Aviv (IL); Nimrod Kadim, Modi'in (IL); Shmuel Glasberg, Herzliya (IL); and Ra'anan Gefen, Re'ut (IL)
Assigned to CogniGuard Medical Holdings Limited, Nicosia (CY)
Filed by CogniGuard Medical Holdings Limited, Nicosia (CY)
Filed on Oct. 27, 2020, as Appl. No. 17/80,878.
Application 17/080,878 is a continuation of application No. 16/066,335, granted, now 10,835,735, issued on Nov. 17, 2020, previously published as PCT/IL2016/051394, filed on Dec. 28, 2016.
Claims priority of provisional application 62/271,664, filed on Dec. 28, 2015.
Prior Publication US 2021/0038880 A1, Feb. 11, 2021
Int. Cl. A61N 1/04 (2006.01); A61N 1/36 (2006.01); A61B 5/0205 (2006.01); A61B 5/00 (2006.01); A61H 23/02 (2006.01); A61N 1/05 (2006.01); A61B 5/11 (2006.01); A61B 5/16 (2006.01); A61N 5/06 (2006.01); A61B 5/024 (2006.01); A61B 5/0245 (2006.01); A61B 5/291 (2021.01); A61B 5/369 (2021.01)
CPC A61N 1/0456 (2013.01) [A61B 5/002 (2013.01); A61B 5/0205 (2013.01); A61B 5/4812 (2013.01); A61B 5/4836 (2013.01); A61H 23/02 (2013.01); A61N 1/0472 (2013.01); A61N 1/0484 (2013.01); A61N 1/0534 (2013.01); A61N 1/36021 (2013.01); A61N 1/36025 (2013.01); A61N 1/36031 (2017.08); A61N 1/36036 (2017.08); A61N 1/36053 (2013.01); A61N 1/36078 (2013.01); A61N 1/36082 (2013.01); A61N 1/36092 (2013.01); A61N 1/36096 (2013.01); A61N 1/36135 (2013.01); A61B 5/0031 (2013.01); A61B 5/0245 (2013.01); A61B 5/02416 (2013.01); A61B 5/1118 (2013.01); A61B 5/163 (2017.08); A61B 5/165 (2013.01); A61B 5/168 (2013.01); A61B 5/291 (2021.01); A61B 5/369 (2021.01); A61B 5/4082 (2013.01); A61B 5/4088 (2013.01); A61B 5/6815 (2013.01); A61B 5/6892 (2013.01); A61B 2560/0219 (2013.01); A61H 2201/0157 (2013.01); A61H 2201/0207 (2013.01); A61H 2201/0214 (2013.01); A61H 2201/165 (2013.01); A61H 2201/5097 (2013.01); A61H 2205/04 (2013.01); A61H 2205/06 (2013.01); A61H 2205/12 (2013.01); A61H 2230/045 (2013.01); A61H 2230/065 (2013.01); A61N 1/3614 (2017.08); A61N 1/36034 (2017.08); A61N 1/36067 (2013.01); A61N 1/36075 (2013.01); A61N 1/36139 (2013.01); A61N 1/36167 (2013.01); A61N 5/0622 (2013.01)] 18 Claims
OG exemplary drawing
 
1. A neuromodulation system for treatment of physiological disorders comprising:
at least one non-invasive cranial nerve stimulator comprising at least two electrodes for stimulating a vagus nerve, wherein at least one electrode of said at least two electrodes is configured to be attached to a concha of an ear, and at least one additional electrode of said at least two electrodes is configured to be attached to a back of the ear;
and
a control unit that controls stimulation by the at least one non-invasive cranial nerve stimulator via said at least two electrodes.